Pharmaceutical companies spend more on clinician office visits (also known as detailing) and free drug samples (also known as sample closets) than any other forms of professional marketing in the United States (totaling $18.5 billion in 2016).1 Detailing and free samples affect prescribing quality and expenditures, often by promoting new and expensive brand-name drugs over equally effective, older, and less expensive options.2 Some hospitals and medical centers have restricted these activities.3 We surveyed a national sample of US outpatient practices delivering primary care to determine the prevalence of detailing and sample closets.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
King AC, Schwartz LM, Woloshin S. A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care. JAMA Intern Med. 2020;180(4):592–595. doi:10.1001/jamainternmed.2019.6770
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: